Skip to main content

Drugs for Sedation

  • Chapter
Quality Control in Endoscopy

Abstract

Modern endoscopic techniques are being practised by a progressively wider spectrum of specialists for a greater range of both diagnostic and increasingly complex therapeutic procedures, particularly in the fields of gastroenterology, urology [1], gynaecology and cardiology, by orthopaedic and vascular surgeons, and interventional radiologists.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Birch BRP, Anson KM, Miller RA (1990) Sedoanalgesia in urology: a safe, cost- effective alternative to general anaesthesia. A review of 1020 cases. Br J Urol 66: 342–350

    Article  PubMed  CAS  Google Scholar 

  2. Department of Health Standing Dental Advisory Commitee (1991) Report of an expert working party. General anaesthesia, sedation and resuscitation in dentistry (In press)

    Google Scholar 

  3. Cockshott ID (1985) Propofol (Diprivan). Pharmacokinetics and metabolism — an overview. Postgrad Med J 61 (Suppl 3): 45–50

    PubMed  CAS  Google Scholar 

  4. Mackenzie N, Grant IS (1987) Propofol for intravenous sedation. Anaesthesia 42: 3–6

    Article  PubMed  CAS  Google Scholar 

  5. Roberts FL, Dixon J, Lewis GTR, Tackley RM, Prys-Roberts C (198S) Induction and maintenance of propofol anaesthesia. A manual infusion scheme. Anaesthesia 43 (Suppl): 14–17

    Google Scholar 

  6. Rudkin GE, Osborne GA, Curtis NJ (1991) Intra-operative patient-controlled sedation. Anaesthesia 46: 90–92

    Article  PubMed  CAS  Google Scholar 

  7. Thompson GE, Moore DC (1971) Ketamine, Diazepam and Innovar. A computerised comparative study. Anesth Analg 50: 458–463

    Article  PubMed  CAS  Google Scholar 

  8. Podiesch I, Dähn H, Engel M (1985) Anaesthetic and side effects of midazolam and ketamine in surgical patients. Anesthesiology 62: 68

    Google Scholar 

  9. Seitz W, Lübbe N, Hamkens A, Bornscheuer A (1988) Midazolam-Ketamin- Kombinationsanaesthesie bei traumatologischen Eingriffen. Anaesthetist 37:231– 237

    CAS  Google Scholar 

  10. Thomson D (ed) (1990) Midazolam and Flumazenil — the agonist-antagonist concept for sedation and anaesthesia. Proceedings of an international symposium, April 1989. Acta Anaesthesiol Scand 34 (Suppl 92) 1–109

    Google Scholar 

  11. Möhler H, Okada T (1977) Benzodiazepine receptor: demonstration in the central nervous system. Science 198: 849–851

    Article  PubMed  Google Scholar 

  12. Braestrup C, Squires RF (1977) Specific benzodiazepine receptors in rat brain characterised by high-affinity 3H-diazepam binding. Proceedings of the National Academy of Sciences USA 74: 3805–3809

    Article  CAS  Google Scholar 

  13. Richards JG, Möhler H (1984) Benzodiazepine receptors. Neuropharmacology 23: 233–242

    Article  PubMed  CAS  Google Scholar 

  14. Braestrup C, Nielsen M (1982) Neurotransmitters and CNS disease; anxiety. Lancet 2: 1030–1034

    Article  PubMed  CAS  Google Scholar 

  15. Chang LR, Barnard EA (1982) The benzodiazepine/GABA receptor complex: molecular size in brain synaptic membranes and in solution. J Neurochem 39:1507– 1518

    Google Scholar 

  16. Schoch P, Richards JG, Häring P, Takacs B, Stähli C, Staehelin T, Haefely W, Möhler H (1985) Co-localisation of GABA and benzodiazepine receptors in the brain. Nature 314: 168–170

    Article  PubMed  CAS  Google Scholar 

  17. Möhler H, Schoch P, Richards JG, Häring P, Takacs B, Stähli C (1986) Monoclonal antibodies: probes for structure and location of the GABA receptor/benzodiazepine receptor/chloride channel complex. In: Benzodiazepine-GABA receptors and chloride channels: structural and functional properties. Olsen RW, Venter JC (eds). New York: Alan R Liss, Inc.

    Google Scholar 

  18. Schofield PR, Darlinson MG, Fujita N, Burt DR, Stephenson FA, Rodriguez H, Rhee LM, Ramachandran J, Reale V, Glencorse TA, Seeburg PH, Barnard EA (1987) Sequence and functional expression of the GABA receptor shows a ligand- gated receptor super-family. Nature 328: 221–227

    Article  PubMed  CAS  Google Scholar 

  19. Erdö S (1985) Peripheral GABA ergic mechanisms. Trends in Pharmacological Sciences 6: 205–208

    Article  Google Scholar 

  20. Mestre M, Carriot T, Belin C, Uzan A, Renault C, Dubroeqcq MC, Gueremy C, Le Fur G (1985) Electrophysiological and pharmacological characterization of peripheral benzodiazepine receptors in a guinea pig heart preparation. Life Sei 35:953– 962

    Google Scholar 

  21. Braestrup C, Nielsen M, Olsen CE (1980) Urinary and brain ß-carboline-3-carboxyla- tes as potent inhibitors of brain benzodiazepine receptors. Proc Natl Acad Sei USA 77: 2288–2292

    Article  CAS  Google Scholar 

  22. Braestrup C, Nielsen M (1981) GABA reduced binding 3H-methyl ß-carboline-car- boxylate to brain benzodiazepine receptors. Nature 294: 472–475

    Article  PubMed  CAS  Google Scholar 

  23. Braestrup C, Schiechen R, Neef G, Nielsen M, Petersen EN (1982) Interaction of convulsive ligands with benzodiazepine receptors. Science 216: 1241–1243

    Article  PubMed  CAS  Google Scholar 

  24. Guidotti A, Forchetti CM, Corda MG, Konkel D, Bennett CD, Costa E (1983) Isolation, characterization and purification to homogeneity of an endogenous polypeptide with agonist action on benzodiazepine receptors. Proc Natl Acad Sei USA 80: 3531–3535

    Article  CAS  Google Scholar 

  25. Editorial (1987) Diazepam binding inhibitor. Lancet 1: 307–308

    Google Scholar 

  26. Ferrero P, Sahti MR, Conti-Tronconi B, Costa E, Guidotti A (1985) Study of an octadecaneuropeptide derived diazepam binding inhibitor (DBI): biological activity and presence in rat brain. Proc Natl Acad Sei USA 83: 827–831

    Article  Google Scholar 

  27. Marquardt H, Todaro GJ, Shoyab M (1986) Complete amino acid sequences of bovine and human endozepines. J Biol Chem 261: 9727–9731

    PubMed  CAS  Google Scholar 

  28. Ferrero P, Guidotti A, Conti-Troncon B, Costa E (1984) A brain octadecaneuropeptide generated by tryptic digestion of DBI (diazepam binding inhibitor) functions as a proconflict ligand of benzodiazepine recognition sites. Neuropharmacology 23: 1359–1362

    Article  PubMed  CAS  Google Scholar 

  29. Little HJ, Nutt DJ, Taylor SC (1987) Kindling and withdrawal changes at the benzodiazepine receptor. Journal of Psychopharmacology 1: 35–46

    Article  CAS  Google Scholar 

  30. Richards JG, Schoch PO, Möhler H, Haefely W (1986) Benzodiazepine receptors resolved. Experientia 42: 121–126

    Article  PubMed  CAS  Google Scholar 

  31. Darragh A, Lambe R, Kenny M, Brick I, O’Boyle C, Taffe W (1982) Rol5-1788 antagonises the central diazepam in man without altering diazepam availability. Br J Clin Pharmacol 14: 677–682

    PubMed  CAS  Google Scholar 

  32. O’Boyle C, Lambe R, Darragh A, Taffe W, Brick I, Kenny M (1983) Rol5-1788 antagonises the effects of diazepam in man without affecting its bioavailability. Br J Anaesth 55: 349–355

    Article  PubMed  Google Scholar 

  33. Amrein R, Hetzel W (1990) Pharmacology of Dormicum (midazolam) and Anexate (Flumazenil). Acta Anaesthesiol Scand (Suppl 92 ) 34: 6 - 15

    Article  CAS  Google Scholar 

  34. Crevoisier C, Ziegler WH, Heizmann P, Dubuis R (1984) Relation entre l’effet clinique et la concentration plasmatique du midazolam chez des sujets volontaires. Ann Fr Anesth Reanim 3: 162–167

    Article  PubMed  CAS  Google Scholar 

  35. Persson MP, Nilsson A, Hartvig P (1988) Relation of sedation and amnesia to plasma concentrations of midazolam in surgical patients. Clin Pharmacol Ther 43:324– 331

    Google Scholar 

  36. Lauven PM, Stoeckel H (1987) Hypnotische wirksame Blutspiegel von Midazolam. Anasth Intensivther Notfallmed 22: 90–93

    Article  PubMed  CAS  Google Scholar 

  37. Raeder JC, Nilsen G, Hole A (1988) Pharmacokinetics of midazolam and alfentanil in outpatient general anaesthesia. Acta Anaesthesiol Scand 32: 467–472

    Article  PubMed  CAS  Google Scholar 

  38. Lauven PM, Schwilden H, Stoeckel H, Greenblatt DJ (1985) The effects of a benzodiazepine antagonist Ro15-1788 in the presence of stable concentrations of midazolam. Anesthesiology 63: 61–64

    Article  PubMed  CAS  Google Scholar 

  39. Riou B, Rimailho A, Galliot M, Bourdon R, Huet Y (1988) Protective cardiovascular effects of diazepam in chloroquine poisoning. Intensive Care Med 14: 610–616

    Article  PubMed  CAS  Google Scholar 

  40. Sanders LD, Davies-Evans J, Rosen M, Robinson JO (1989) Comparison of diazepam with midazolam as i.v. sedation for outpatient gastroscopy. Br J Anaesth 63: 726–731

    Article  PubMed  CAS  Google Scholar 

  41. Whitwam JG, Al-Khudhairi D, McCloy RF (1983) Comparison of midazolam and diazepam in doses of comparable potency during gastroscopy. Br J Anaesth 55: 773–777

    Article  PubMed  CAS  Google Scholar 

  42. Gamble JAS, Kawar P, Dundee JW, Moore J, Briggs LP (1981) Evaluation of midazolam as an intravenous induction agent. Anaesthesia 36: 868–873

    Article  PubMed  CAS  Google Scholar 

  43. Bell GD, Antrobus JHL, Lee J, Coady T, Morden A (1990) Bolus or slow titrated injection of midazolam prior to upper gastrointestinal endoscopy? Relative effect on oxygen saturation and prophylactic value of supplemental oxygen. Alimentary Pharmacology and Therapeutics 4: 393–401

    Article  PubMed  CAS  Google Scholar 

  44. Swain DG, Ellis DJ, Bradby H (1990) Rapid intravenous low-dose diazepam as sedation for upper gastrointestinal endoscopy. Alimentary Pharmacology and Therapeutics 4: 43–48

    Article  PubMed  CAS  Google Scholar 

  45. Dundee JW, Collier PS, Carlisle RJT, Harper KW (1986) Prolonged midazolam elimination half-life. Br J Clin Pharmacol 21: 425–429

    PubMed  CAS  Google Scholar 

  46. Kassai A, Toth G, Eichelbaum M, Klotz U (1988) No evidence of a genetic polymorphism in the oxidative metabolism of midazolam. Clin Pharmacokinet 15:319– 325

    Google Scholar 

  47. Adams P, Gelman S, Reves JG, Alvis M, Greenblatt DT et al (1985) Midazolam pharmacokinetics and pharmacodynamics during acute hypovolemia. Anesthesiology 63: 140–146

    Article  PubMed  CAS  Google Scholar 

  48. Shelly MP, Mendel L, Park GR (1987) Failure of critically ill patients to metabolise midazolam. Anaesthesia 42: 619–626

    Article  PubMed  CAS  Google Scholar 

  49. Kalow W (1982) Ethnic differences in drug metabolism. Clin Pharmacokinet 7: 373–400

    Article  PubMed  CAS  Google Scholar 

  50. Cook PJ, Bennett PN, Lennard-Jones JE, Warnes TW (1978) Premedication for endoscopy. Scand J Gastroenterol 13: 33–39

    Article  PubMed  CAS  Google Scholar 

  51. Swenzen GO, Chakrabarti MK, Sapsed-Byrne S, Whitwam JG (1988) Selective depression by alfentanil of Group III and IV somatosympathetic reflexes in the dog. Br J Anaesth 61: 441–445

    Article  PubMed  CAS  Google Scholar 

  52. Whitwam JG (1988) Summary of meeting. In:Kallar SK, Whitwam JG (eds). Outpatient anaesthesia. Proceedings of an international symposium, Antwerp, Belgium, 9th June 1988 Amsterdam: Medicom

    Google Scholar 

  53. Ben-Shlomo I, Abd-El-Khalim H, Ezry J, Zohar S, Tverskoy M (1990) Midazolam acts synergistically with fentanyl for induction of anaesthesia. Br J Anaesth 64: 45–47

    Article  PubMed  CAS  Google Scholar 

  54. Vinik HR, Bradley EL, Kissin I (1989) Midazolam-alfentanil synergism for anaesthetic induction in patients. Anesth Analg 69: 213–217

    Article  PubMed  CAS  Google Scholar 

  55. Tverskoy M, Fleyshman G, Bradley EL, Kissin I (1988) Midzolam-thiopental anesthetic interaction in patients. Anesth Analg 67: 342–345

    PubMed  CAS  Google Scholar 

  56. Tverskoy M, Ben-Shlomo I, Ezry J, Finger J, Fleyshman G (1989) Midazolam acts synergistically with methohexitone for induction of anaesthesia. Br J Anaesth 63: 109–122

    Article  PubMed  CAS  Google Scholar 

  57. Tverskoy M, Fleyshman G, Ezry J, Bradley EL, Kissin I (1989)Midzolam-morphine sedative interaction in patients. Anesth Analg 68: 282–285

    Google Scholar 

  58. Tucker MR, Ochs MW, White PW (1986) Arterial blood gas levels after midazolam or diazepam administered with or without fentanyl as an intravenous sedative for outpatient surgical procedures. J Oral Maxillofac Surg 44:688– 692

    Google Scholar 

  59. Dolan EA, Murray WJ, Immediata AR, Gleason N (1988) Comparison of nalbuphine and fentanyl in combination with diazepam for outpatient oral surgery. J Oral Maxillofac Surg 46: 471–473

    Article  PubMed  CAS  Google Scholar 

  60. Sury MR J, Cole PV (1988) Nalbuphine combined with midazolam for outpatient sedation. An assessment in fibreoptic bronchoscopy patients. Anaesthesia 43:285– 288

    Google Scholar 

  61. Romagnoli A, Keats AS (1980) Ceiling effect for respiratory depression by nalbuphine. Clin Pharmacol Ther 27: 478–485

    Article  PubMed  CAS  Google Scholar 

  62. Elwood RJ, Hildebrand PJ, Dundee JW, Collier PS (1983) Ranitidine influences the uptake of oral midazolam. Br J Clin Pharmacol 15: 743–745

    PubMed  CAS  Google Scholar 

  63. Fee JPH, Collier PS, Howard PJ, Dundee JW (1987) Cimetidine and ranitidine increase midazolam bioavailability. Clin Pharmacol Ther 41: 80–84

    Article  PubMed  CAS  Google Scholar 

  64. Knüchel M, Ochs HR, Verbrug-Ochs B, Labedzki L, Greenblatt DJ (1987) Interaktion von Ranitidin und Cimetidin mit Midazolam bei intravenöser und oraler Gabe. Med Welt 38: 244–248

    Google Scholar 

  65. Buckley MMT, Brogden RM (1990) Ketorolac. A review of the pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 39:86– 109

    Google Scholar 

  66. Amrein R, Leishman B, Bentzinger C, Roncari G (1987) Flumazenil in benzodiazepine antagonism. Actions and clinical use in intoxication and anaesthesiology. Medical Toxicology 2: 411–429

    Google Scholar 

  67. Klotz U, Kanto J (1988) Pharmacokinetics and clinical use of flumazenil. Clin Pharmacokinet 14: 1–12

    Article  PubMed  CAS  Google Scholar 

  68. Whitwam JG (1988) Flumazenil: a benzodiazepine antagonist. Br Med J 297: 999–1000

    Article  CAS  Google Scholar 

  69. Fisher GC, Hutton P (1989) Cardiovascular responses to flumazenil-induced arousal after arterial surgery. Anaesthesia 44: 104–106

    Article  PubMed  CAS  Google Scholar 

  70. Wolff J, Carl P, Clausen TG, Mikkelsen BO (1986) Rol5-1788 for postoperative recovery. A randomised clinical trial in patients undergoing minor surgical procedures under midazolam anaesthesia. Anaesthesia 41: 1001–1006

    Google Scholar 

  71. Alon E, Baitella L, Hossli G (1987) Double-blind study of the reversal of midazolam- supplemented general anaesthesia with Rol5-1788. Br J Anaesth 59: 455–458

    Article  PubMed  CAS  Google Scholar 

  72. Data on file. F Hoffmann-La Roche Ltd., Basle, Switzerland

    Google Scholar 

  73. Ricou R, Forster A, Bruckner A, Chastonay P, Gemperle M (1986) Clinical evaluation of a specific benzodiazepine antagonist (Ro 15-1788). Studies in elderly patients after regional anaesthesia under benzodiazepine sedation. Br J Anaesth 58: 1005–1011

    Google Scholar 

  74. Sage DJ, Chase A, Boas RA (1987) Reversal of midazolam sedation with Anexate. Br J Anaesth 59: 459–464

    Article  PubMed  CAS  Google Scholar 

  75. Jensen S, Knudsen L, Kirkegaard L (1988) Flumazenil used in the antagonizing of diazepam and midazolam sedation in outpatients undergoing gastroscopy. Eur J Anaesthesiol Suppl 2: 161–166

    PubMed  CAS  Google Scholar 

  76. Rodrigo C, Rosenquist JB (1987) The effect of Rol5-1788 ( Anexate) on conscious sedation produced with midazolam. Anaesth Intensive Care 15: 185–192

    Google Scholar 

  77. Holloway AM, Logan DA (1988) The use of flumazenil to reverse diazepam sedation after endoscopy. Eur J Anaesthesiol Suppl 2: 191–198

    Google Scholar 

  78. Kirkegaard I, Knudsen L, Jensen S, Kruse A (1986) Benzodiazepine antagonist Ro15-1788. Antagonism of diazepam sedation in outpatients undergoing gastroscopy. Anaesthesia 41: 1184–1188

    Google Scholar 

  79. Andrews PJD, Wright DJ, Lamont MC (1988) Flumazenil in the outpatient. A study following midazolam as sedation for upper gastrointestinal endoscopy of sedation and amnesia to plasma concentrations of midazolam in surgical patients. Clin Pharmacol Ther 43: 324–331

    Google Scholar 

  80. Nutt D, Glue P, Lawson C, Wilson S (1990) Flumazenil provocation of panic attacks. Arch Gen Psychiatry 47: 917–925

    PubMed  CAS  Google Scholar 

  81. Louis M, Forster A, Suter PM, Gemperle M (1984) Clinical and haemodynamic effects of a specific benzodiazepine antagonist (Ro 15–1788) after open heart surgery. Anesthesiology 513A

    Google Scholar 

  82. Editorial (1988) Midazolam — is antagonism justified? Lancet 1: 140–142

    Google Scholar 

  83. Ashton H (1984) Benzodiazepine withdrawal: an unfinished story. Br Med J 288: 1135–1140

    Article  CAS  Google Scholar 

  84. Cumin R, Bonetti EP, Scherschlicht R, Haefely WE (1982) Use of the specific benzodiazepine antagonist Rol5~1788 in studies of physiological dependence on benzodiazepine. Experientia 38: 833–834

    Article  PubMed  CAS  Google Scholar 

  85. Savic I, Widen L, Stone-Elander S (1991) Feasibility of reversing benzodiazepine tolerance with flumazenil. Lancet 337: 133–137

    Article  PubMed  CAS  Google Scholar 

  86. Bell GD, Reeve PA, Moshiri M et al (1987) Intravenous midazolam: a study of the degree of oxygen desaturation occurring during upper-gastrointestinal endoscopy. Br J Clin Pharmacol 23: 703–708

    PubMed  CAS  Google Scholar 

  87. Mora CT, Torjman M, White PF (1989) Effects of diazepam and flumazenil on sedation and hypoxic ventilatory response. Anesth Analg 68: 473–478

    Article  PubMed  CAS  Google Scholar 

  88. Power SJ, Chakrabarti MK, Whitwam JG (1984) Response to carbon dioxide after oral midazolam and pentobarbitone. Anaesthesia 39: 1183–1187

    Article  PubMed  CAS  Google Scholar 

  89. Deham A, Ward DS (1991) Effect of i.v. midazolam on the ventilatory response to substained hypoxia in man. Br J Anaesth 66: 454–457

    Article  Google Scholar 

  90. Forster A, Fardaz JP, Suter PM, Gemperle M (1980) Respiratory depression by midazolam and diazepam. Anesthesiology 53: 494–497

    Article  PubMed  CAS  Google Scholar 

  91. Power SJ, Morgan M, Chakrabarti MK (1983) Carbon dioxide response curves following midazolam and diazepam. Br J Anaesth 55: 837–841

    Article  PubMed  CAS  Google Scholar 

  92. Dundee JW, Wyant GM (1974) Intravenous anaesthesia. Edinburgh: Churchill Livingstone

    Google Scholar 

  93. Al-Khudhairi D, Askitopoulou H, Whitwam JG (1982) Acute tolerance to the central respiratory effects of midazolam in the dog. Br J Anaesth 54: 953–958

    Article  PubMed  CAS  Google Scholar 

  94. Weinbrum A, Geller E (1990) The respiratory effects of reversing midazolam sedation with flumazenil in the presence or absence of narcotics. Acta Anaesthesiol Scand Suppl 92 34: 65–69

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Whitwam, J. (1991). Drugs for Sedation. In: McCloy, R., Davies, A.P. (eds) Quality Control in Endoscopy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77138-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-77138-5_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-77140-8

  • Online ISBN: 978-3-642-77138-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics